DrAid
AI-powered medical imaging analysis platform for radiology
Platform · Cloud SaaSCompany source
Company profile
About VinBrain Joint Stock Company
VinBrain Joint Stock Company operates in the medical imaging and radiology sector, focusing on AI-powered healthcare solutions. Based on the available information, the company appears to be developing artificial intelligence technologies for medical imaging applications. However, the scraped website content primarily displays NVIDIA AI platform information rather than VinBrain-specific company details, which may indicate the website is undergoing maintenance, has been redirected, or is hosted on NVIDIA infrastructure. VinBrain is known in the healthcare AI space for developing AI-assisted diagnostic tools for radiology and medical imaging analysis. The company's solutions are designed to support radiologists and healthcare providers in improving diagnostic accuracy and efficiency through advanced AI algorithms applied to medical images.
Company description VinBrain Joint Stock Company official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at VinBrain Joint Stock Company?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Health Systems
- Providers
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
DrAid for Liver SegmentationK241543 · 510k · Dec 6, 2024
DrAid for Radiology v1K221241 · 510k · Sep 1, 2022
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from VinBrain Joint Stock Company
Recent articles published on VinBrain Joint Stock Company's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.